MedTrace Logo

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

NCT01306864 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2018-02-05

No results posted yet for this study

Summary

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Conditions

  • Bleeding Peptic Ulcers

Interventions

DEVICE

Hemospray Kit

Hemostasis of Arterial GI Bleeding

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2017-04-30
Completion
2017-05-29

Countries

  • Canada
  • Hong Kong
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01306864 on ClinicalTrials.gov